Galena Biopharma, Inc. (Galena), formerly RXi Pharmaceuticals Corporation, is a biotechnology company focused on discovering, developing and commercializing therapies addressing unmet medical needs using RNAi-targeted and immunotherapy technologies. Galena is pursuing cancer therapies utilizing peptide-based immunotherapy products, including its main product candidate NeuVaxtm, for the treatment of various cancers and therapeutics based on RNA interference (RNAi), a naturally occurring cellular mechanism that with, or silence, expression of targeted disease-associated genes. The Company's main product is NeuVax, which is a peptide-based immunotherapy to reduce the recurrence of breast cancer in low-to-intermediate HER2-positive breast cancer patients not eligible for Herceptin. RXI-109, its RNAi product is a dermal anti-scarring therapy that targets connective tissue growth factor (CTGF). In April 13, 2011, it acquired Apthera, Inc. (Apthera), a private biotechnology company.
Wow! what a move on heavy volume today. This stock moved nicely on good volume as traders and investors started looking for ways to make money in the market today.
This stock moved higher today after an analyst from Gabelli announced that the market for cardiac rhythm devices was as bad as it had ever been. My guess is that this stock was shorted to death and was therefore moving up because it got some exposure.
Take a look at the chart, and you will notice that the green candle shown here is typically followed by a red candle. Careful with this one
sign up for out charts and profiles today!http://www.bullseyestox.com/gale-up-huge-what-happened